DK1420774T3 - Fremstilling og diabetisk anvendelse af gibberelliner - Google Patents
Fremstilling og diabetisk anvendelse af gibberellinerInfo
- Publication number
- DK1420774T3 DK1420774T3 DK02753918T DK02753918T DK1420774T3 DK 1420774 T3 DK1420774 T3 DK 1420774T3 DK 02753918 T DK02753918 T DK 02753918T DK 02753918 T DK02753918 T DK 02753918T DK 1420774 T3 DK1420774 T3 DK 1420774T3
- Authority
- DK
- Denmark
- Prior art keywords
- gibberellins
- preparation
- diabetic
- diabetic use
- nephropathy
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 3
- 229930191978 Gibberellin Natural products 0.000 title abstract 2
- 239000003448 gibberellin Substances 0.000 title abstract 2
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical class C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 title abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 206010054805 Macroangiopathy Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000030533 eye disease Diseases 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 208000017169 kidney disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 201000001119 neuropathy Diseases 0.000 abstract 1
- 230000007823 neuropathy Effects 0.000 abstract 1
- 238000010606 normalization Methods 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 208000033808 peripheral neuropathy Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000004962 physiological condition Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 230000036269 ulceration Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPR7380A AUPR738001A0 (en) | 2001-08-31 | 2001-08-31 | Compound for medicinal purposes |
| AU2002950182A AU2002950182A0 (en) | 2002-07-12 | 2002-07-12 | Compounds for medicinal purposes |
| PCT/AU2002/001083 WO2003018069A1 (en) | 2001-08-31 | 2002-08-12 | Preparation and diabetic use of gibberellins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1420774T3 true DK1420774T3 (da) | 2008-11-24 |
Family
ID=25646789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02753918T DK1420774T3 (da) | 2001-08-31 | 2002-08-12 | Fremstilling og diabetisk anvendelse af gibberelliner |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US7435756B2 (de) |
| EP (1) | EP1420774B1 (de) |
| JP (2) | JP4596777B2 (de) |
| KR (1) | KR100898519B1 (de) |
| CN (1) | CN1242741C (de) |
| AT (1) | ATE401876T1 (de) |
| AU (1) | AU2002322165B2 (de) |
| BR (1) | BR0212150A (de) |
| CA (1) | CA2458797C (de) |
| CY (1) | CY1108394T1 (de) |
| DE (1) | DE60227820D1 (de) |
| DK (1) | DK1420774T3 (de) |
| ES (1) | ES2309187T3 (de) |
| HK (1) | HK1069778A1 (de) |
| IL (1) | IL160435A0 (de) |
| NZ (1) | NZ530990A (de) |
| PT (1) | PT1420774E (de) |
| RU (1) | RU2310444C2 (de) |
| WO (1) | WO2003018069A1 (de) |
| ZA (1) | ZA200401549B (de) |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB821733A (en) * | 1957-04-05 | 1959-10-14 | Ici Ltd | Isolation process |
| GB1174924A (en) * | 1966-11-03 | 1969-12-17 | Ici Ltd | Separation Process for Gibberellic Acid |
| ATE5538T1 (de) * | 1979-09-04 | 1983-12-15 | Norsk Hydro A/S | Fermentationsverfahren zur herstellung eines gibberellins. |
| JPS58152499A (ja) * | 1982-03-05 | 1983-09-10 | Kyowa Hakko Kogyo Co Ltd | ジベレリンａ４の製造法 |
| US4424232A (en) * | 1982-05-19 | 1984-01-03 | Parkinson Richard W | Treatment of herpes simplex |
| GB8606253D0 (en) * | 1986-03-13 | 1986-04-16 | Wyeth John & Brother Ltd | Pyrimidoindoles |
| JPH025531A (ja) * | 1988-06-24 | 1990-01-10 | Matsushita Electron Corp | 半導体装置の製造方法 |
| JP2797331B2 (ja) * | 1988-08-31 | 1998-09-17 | 三菱化学株式会社 | 新規微生物及びジベレリン類の製造方法 |
| JPH02165775A (ja) | 1988-12-20 | 1990-06-26 | Toshiba Corp | 画像処理装置 |
| US5580857A (en) * | 1989-12-12 | 1996-12-03 | Oden; Per | Use of gibberellins for the treatment of prostatitis |
| US5591709A (en) * | 1991-08-30 | 1997-01-07 | Life Medical Sciences, Inc. | Compositions and methods for treating wounds |
| SE9301606D0 (sv) * | 1993-05-07 | 1993-05-07 | Per-Christer Oden | Composition for the treatment of impaired hair growth |
| WO1996020703A1 (en) * | 1995-01-06 | 1996-07-11 | Australian Biomedical Company Pty. Ltd. | Compounds for veterinary and medicinal applications |
| JPH11508894A (ja) * | 1995-06-30 | 1999-08-03 | メルク エンド カンパニー インコーポレーテッド | Ａｃｅ阻害剤とａｉｉ拮抗薬を用いる腎疾患の治療方法 |
| IT1276130B1 (it) * | 1995-11-14 | 1997-10-27 | Gentili Ist Spa | Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo |
| US6312663B1 (en) * | 1999-03-19 | 2001-11-06 | Joseph V. Boykin, Jr. | Prediction of diabetes impaired wound healing by urinary nitrate assay |
| US6287800B1 (en) * | 1999-08-31 | 2001-09-11 | Jorge L. Gallazzo | Production of high titers of gibberellins, GA4 and GA7, by Gibberella fujikuroi strain LTB-1027 |
-
2002
- 2002-08-12 BR BR0212150-6A patent/BR0212150A/pt not_active Application Discontinuation
- 2002-08-12 DK DK02753918T patent/DK1420774T3/da active
- 2002-08-12 IL IL16043502A patent/IL160435A0/xx unknown
- 2002-08-12 RU RU2004109584/15A patent/RU2310444C2/ru active
- 2002-08-12 CA CA2458797A patent/CA2458797C/en not_active Expired - Lifetime
- 2002-08-12 CN CNB028160126A patent/CN1242741C/zh not_active Expired - Fee Related
- 2002-08-12 WO PCT/AU2002/001083 patent/WO2003018069A1/en active IP Right Grant
- 2002-08-12 AU AU2002322165A patent/AU2002322165B2/en not_active Expired
- 2002-08-12 DE DE60227820T patent/DE60227820D1/de not_active Expired - Lifetime
- 2002-08-12 ES ES02753918T patent/ES2309187T3/es not_active Expired - Lifetime
- 2002-08-12 AT AT02753918T patent/ATE401876T1/de active
- 2002-08-12 KR KR1020047002836A patent/KR100898519B1/ko active IP Right Grant
- 2002-08-12 PT PT02753918T patent/PT1420774E/pt unknown
- 2002-08-12 EP EP02753918A patent/EP1420774B1/de not_active Expired - Lifetime
- 2002-08-12 JP JP2003522584A patent/JP4596777B2/ja not_active Expired - Lifetime
- 2002-08-12 NZ NZ530990A patent/NZ530990A/en not_active IP Right Cessation
-
2004
- 2004-02-12 US US10/776,188 patent/US7435756B2/en not_active Expired - Lifetime
- 2004-02-25 ZA ZA2004/01549A patent/ZA200401549B/en unknown
-
2005
- 2005-03-17 HK HK05102331A patent/HK1069778A1/xx not_active IP Right Cessation
- 2005-05-20 US US11/133,207 patent/US20050215496A1/en not_active Abandoned
-
2006
- 2006-08-24 US US11/508,897 patent/US7968596B2/en not_active Expired - Fee Related
-
2008
- 2008-10-06 CY CY20081101100T patent/CY1108394T1/el unknown
-
2009
- 2009-02-09 JP JP2009027931A patent/JP4885989B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| NZ530990A (en) | 2005-08-26 |
| JP2009100775A (ja) | 2009-05-14 |
| WO2003018069A1 (en) | 2003-03-06 |
| US7968596B2 (en) | 2011-06-28 |
| HK1069778A1 (en) | 2005-06-03 |
| US20070197456A1 (en) | 2007-08-23 |
| ES2309187T3 (es) | 2008-12-16 |
| RU2310444C2 (ru) | 2007-11-20 |
| CA2458797A1 (en) | 2003-03-06 |
| IL160435A0 (en) | 2004-07-25 |
| EP1420774A1 (de) | 2004-05-26 |
| US20050215496A1 (en) | 2005-09-29 |
| CN1242741C (zh) | 2006-02-22 |
| ATE401876T1 (de) | 2008-08-15 |
| PT1420774E (pt) | 2008-08-11 |
| JP4885989B2 (ja) | 2012-02-29 |
| KR100898519B1 (ko) | 2009-05-20 |
| JP4596777B2 (ja) | 2010-12-15 |
| CN1543343A (zh) | 2004-11-03 |
| US20040162248A1 (en) | 2004-08-19 |
| KR20040031008A (ko) | 2004-04-09 |
| US7435756B2 (en) | 2008-10-14 |
| AU2002322165B2 (en) | 2006-10-26 |
| EP1420774B1 (de) | 2008-07-23 |
| BR0212150A (pt) | 2004-07-13 |
| ZA200401549B (en) | 2005-01-26 |
| EP1420774A4 (de) | 2006-07-05 |
| CY1108394T1 (el) | 2014-02-12 |
| DE60227820D1 (de) | 2008-09-04 |
| CA2458797C (en) | 2011-01-18 |
| JP2005501864A (ja) | 2005-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1213296E (pt) | Derivados de glucopiranosiloxipirazole composicoes medicas que os contem e intermediarios na sua producao | |
| WO2009023718A3 (en) | Novel activators of glucokinase | |
| EP1609798A4 (de) | Kondensiertes heterocyclisches derivat, dieses enthaltende medizinische zusammensetzung und deren medizinische verwendung | |
| BR0014679A (pt) | 2-tio-3,5-diciano-4-aril-6-aminopiridinas substituìdas e sua aplicação | |
| BRPI0512974A (pt) | novos derivados de hidantoìna para o tratamento de doenças obstrutivas das vias aéreas | |
| BR0009864A (pt) | Composto, composição farmacêutica, métodos para o tratamento de doenças, para o tratamento e/ou prevenção de condições mediadas pelos receptores nucleares e para o tratamento e/ou prevenção de diabete e/ou obesidade, e, uso de um composto | |
| BG108225A (en) | Thiohydantoins and use thereof for treating diabetes | |
| SE0102299D0 (sv) | Compounds | |
| BR0210838A (pt) | Composto, formulação farmacêutica, uso de um composto, métodos de prevenção e/ou tratamento de condições associadas com glicogênio sintase quinase-3, e de doenças, e medicação contraceptiva, e, processos para a preparação de um composto | |
| WO2004026863A8 (en) | Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors | |
| PL375473A1 (en) | Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof | |
| MY132789A (en) | Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals | |
| WO2007076092A3 (en) | Nitrogen- containing bicyclic hetroaryl compounds for the treatment of raf protein kinase-mediated diseases | |
| MY140187A (en) | Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them | |
| WO2006050389A3 (en) | Pyridazine compounds, compositions and methods | |
| BR9906813A (pt) | Método para administração de insulina aspb28- humana | |
| NO20083411L (no) | Indaneddiksyrederivater og deres anvendelse som farmasoytiske midler, intermediater og fremgangsmater for fremstilling | |
| DE60034240D1 (de) | Drogen zur behandlung maligner tumoren | |
| MY142830A (en) | Propionic acid derivatives useful in the treatment of lipid disorders | |
| BRPI0111591B8 (pt) | composto, composição farmacêutica, e, usos de um composto | |
| WO2003051389A3 (en) | Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof | |
| BRPI0412997A (pt) | derivados de dióxido de tiazol-benzoisotiazol substituìdos, método para produzir os mesmos e seu uso | |
| WO2003087062A3 (en) | 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation | |
| WO2006050359A3 (en) | Pyridazine compounds and methods | |
| BR0107902A (pt) | Composto, composição farmacêutica, métodos para o tratamento de doenças, e para o tratamento e/ou prevençao de, condições mediadas por receptores nucleares, e diabetes e/ou obesidade, uso de uim composto, processo para a preparação de um composto, e, método para tratar diabetes de tipo i, diabetes de tipo ii, tolerância prejudicada à glucose, resistência à insolina ou obesidade |